(Hypertension. 1995;25:1034-1041.)
© 1995 American Heart Association, Inc.
Articles |
From the Division of Cardiology, Veterans General Hospital-Taipei (C.-H.C., S.-J.L., T.-L.H., S.-P.W., M.-S.C.); the Veterans General Hospital-Taichung (C.-T.T.), Republic of China; the Division of Cardiology, Johns Hopkins Hospital, Baltimore, Md (F.C.P.Y., C.O.S.); and the Institute of Public Health, National Yang-Ming University, Taipei (P.C.), Republic of China.
Correspondence to Chen-Huan Chen, MD, Division of Cardiology, Department of Medicine, Veterans General Hospital-Taipei, Shih-Pai, Taipei, Taiwan, 11217, ROC.
Abstract We conducted this study to compare the effects of
fosinopril versus atenolol on peripheral blood pressure, central
arterial wave reflection, and left ventricular mass in a group of
patients with essential hypertension. We conducted a double-blind,
randomized trial of fosinopril and atenolol in 79 hypertensive patients
(52 men, 27 women; mean age, 45.8±8.5 years; range, 30 to 68 years).
Carotid pressure waveforms were recorded noninvasively by applanation
tonometry with a Millar micromanometer-tipped probe. The extent of wave
reflection was estimated by the augmentation index defined as the ratio
of the amplitude of pressure wave above its systolic shoulder to the
pulse pressure. The augmentation index, left ventricular mass index by
two-dimensional echocardiography, and 24-hour ambulatory blood
pressures were determined before and after 8 weeks of daily treatment
with fosinopril (10 to 20 mg) or atenolol (50 to 100 mg) with or
without diuretics and compared with those values in 79 normotensive
control subjects. After 8 weeks of treatment, both drugs lowered
24-hour ambulatory peripheral systolic and diastolic pressures into the
normal range to a similar extent (fosinopril, -18/-13 mm Hg;
atenolol, -23/-17 mm Hg, both P=NS). On the other hand,
whereas the elevated augmentation index in hypertensive patients
compared with normotensive subjects (16±11% versus 10±8%) was
completely normalized by fosinopril (-9.3±9.8%, P
.002),
it was lowered by atenolol (-4.8±8.9%, P<.002) but to a
significantly smaller extent (fosinopril versus atenolol effect,
P=.04). Neither drug affected the slightly elevated left
ventricular mass index (fosinopril, 93±13 gm/m2; atenolol,
98±20 gm/m2) compared with normotensive subjects (86±13
gm/m2). At the doses used, fosinopril and atenolol reduced
peripheral blood pressure similarly but had different effects on
central systolic wave reflections, implying a greater effect of
fosinopril than atenolol in reducing central blood pressure than is
apparent from measurements of peripheral pressure. Left ventricular
mass was only slightly elevated in these mild hypertensive patients and
was not altered after 8 weeks of treatment.
Key Words: hypertension, essential tonometry fosinopril atenolol
This article has been cited by other articles:
![]() |
R. H. Fagard, H. Celis, L. Thijs, and S. Wouters Regression of Left Ventricular Mass by Antihypertensive Treatment: A Meta-Analysis of Randomized Comparative Studies Hypertension, November 1, 2009; 54(5): 1084 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Manisty, A. Zambanini, K. H. Parker, J. E. Davies, D. P. Francis, J. Mayet, S. A. McG Thom, A. D. Hughes, and on behalf of the Anglo-Scandinavian Cardiac Outcom Differences in the Magnitude of Wave Reflection Account for Differential Effects of Amlodipine- Versus Atenolol-Based Regimens on Central Blood Pressure: An Anglo-Scandinavian Cardiac Outcome Trial Substudy Hypertension, October 1, 2009; 54(4): 724 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Williams, P. S. Lacy, and for the CAFE and the ASCOT (Anglo-Scandinavian Car Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) Study: CAFE-Heart Rate. J. Am. Coll. Cardiol., August 18, 2009; 54(8): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Gupta Beta-blockers, hypertension, and randomized controlled trials: science and sensibility. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2102 - 2103. [Full Text] [PDF] |
||||
![]() |
R. Dietz, R. Dechend, C.-M. Yu, M. Bheda, J. Ford, M. F. Prescott, and D. L. Keefe Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension1 Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 163 - 175. [Abstract] [PDF] |
||||
![]() |
B. A. Nier, L. S. Harrington, M. J. Carrier, and P. D. Weinberg Evidence for a specific influence of the nitrergic pathway on the peripheral pulse waveform in rabbits Exp Physiol, April 1, 2008; 93(4): 503 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Safar Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension Hypertension, July 1, 2007; 50(1): 167 - 171. [Full Text] [PDF] |
||||
![]() |
A. M. Dart, J. D. Cameron, C. D. Gatzka, K. Willson, Y.-L. Liang, K. L. Berry, L. M.H. Wing, C. M. Reid, P. Ryan, L. J. Beilin, et al. Similar Effects of Treatment on Central and Brachial Blood Pressures in Older Hypertensive Subjects in the Second Australian National Blood Pressure Trial Hypertension, June 1, 2007; 49(6): 1242 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
The CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial, CAFE Steering Committee and Writing Committee, B. Williams, P. S. Lacy, S. M. Thom, K. Cruickshank, A. Stanton, D. Collier, A. D. Hughes, et al. Differential Impact of Blood Pressure-Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study Circulation, March 7, 2006; 113(9): 1213 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Pauca, N D Kon, and M F O'Rourke Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries Heart, November 1, 2005; 91(11): 1428 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davies, E. Carr, M. Band, A. Morris, and A. Struthers Do Losartan and Atenolol have Differential Effects on BNP and Central Haemodynamic Parameters? Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 151 - 153. [Abstract] [PDF] |
||||
![]() |
J. Amar, J.-B. Ruidavets, J.-C. Peyrieux, J.-M. Mallion, J. Ferrieres, M. E. Safar, and B. Chamontin C-Reactive Protein Elevation Predicts Pulse Pressure Reduction in Hypertensive Subjects Hypertension, July 1, 2005; 46(1): 151 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Meijboom, B. E. Westerhof, G. J. Nollen, J. A.E. Spaan, B. A.J.M. de Mol, M. J.H.M. Jacobs, and B. J.M. Mulder Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 901 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mahmud and J. Feely Review: Arterial stiffness and the renin-angiotensin-aldosterone system Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 102 - 108. [Abstract] [PDF] |
||||
![]() |
C. M. McEniery, M. Schmitt, A. Qasem, D. J. Webb, A. P. Avolio, I. B. Wilkinson, and J. R. Cockcroft Nebivolol Increases Arterial Distensibility In Vivo Hypertension, September 1, 2004; 44(3): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. London, R. G. Asmar, M. F. O'Rourke, M. E. Safar, and REASON Project Investigators Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenolol J. Am. Coll. Cardiol., January 7, 2004; 43(1): 92 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
C L Turner, N Mendoza, R D Illingworth, and P J Kirkpatrick Measurement of pulse pressure profiles in patients with trigeminal neuralgia J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 533 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Oliver and D. J. Webb Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Stokes, E. S. Barin, and K. L. Gilfillan Effects of Isosorbide Mononitrate and AII Inhibition on Pulse Wave Reflection in Hypertension Hypertension, February 1, 2003; 41(2): 297 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Asmar, P. Gosse, J. Topouchian, G. N'tela, A. Dudley, and G. L Shepherd Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 176 - 180. [Abstract] [PDF] |
||||
![]() |
X J Jiang, M F O'Rourke, W Q L Jin, L S Liu, C W Li, P C Tai, X C Zhang, and S Z Liu Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform Heart, August 1, 2002; 88(2): 143 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Asmar, G. M. London, M. E. O'Rourke, and M. E. Safar Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol Hypertension, October 1, 2001; 38(4): 922 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Pauca, M. F. O'Rourke, and N. D. Kon Prospective Evaluation of a Method for Estimating Ascending Aortic Pressure From the Radial Artery Pressure Waveform Hypertension, October 1, 2001; 38(4): 932 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Weinsaft, M. F. O'Rourke, W. W. Nichols, A. M. Sharma, T. Pischon, S. Engeli, H. Gavras, S. Yusuf, and G. S. Francis Effect of Ramipril on Cardiovascular Events in High-Risk Patients N. Engl. J. Med., July 6, 2000; 343(1): 64 - 66. [Full Text] |
||||
![]() |
M. J. Domanski, G. F. Mitchell, J. E. Norman, D. V. Exner, B. Pitt, and M. A. Pfeffer Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction J. Am. Coll. Cardiol., March 15, 1999; 33(4): 951 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chen, C.-T. Ting, A. Nussbacher, E. Nevo, D. A. Kass, P. Pak, S.-P. Wang, M.-S. Chang, and F. C.P. Yin Validation of Carotid Artery Tonometry as a Means of Estimating Augmentation Index of Ascending Aortic Pressure Hypertension, February 1, 1996; 27(2): 168 - 175. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |